Preclinical Stage Bispecific Antibodies in Active Development – 2021
90 Bi-specific Antibody Name, Target, Developer, Partner, Highest Phase of Development, NCT Number, Cancer Indications etc.
ImmunoOncology
Clinical Stage Bispecific Antibodies in Active Development – 2021
109 Bi-specific Antibody Name, Target, Developer, Partner, Highest Phase of Development, NCT Number, Cancer Indications etc.
Emerging Drug Developers Developing Cancer Targeting Exosomes
Exosomes are cell-derived nanovesicles, which are usually 50-150 nm in diameter and are involved in the intercellular transportation of materials....
Read more
Mapping Bio-Innovations
updated.. easy.. precise... complete...
Presenting filtered comprehensive information. Gain more insights on emerging bio-business, frame strategies, grow faster & better connect with biological science community.
LEARN MORE »
